Labshake search
Citations for R&D Systems :
1 - 50 of 2146 citations for Human Apolipoprotein AI B Free Serum since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biophysics 2022Quote: Human Apolipoprotein B Quantikine ELISA Kit (R&D Systems, DAPB00) was used according to manufacturer’s instructions ...
-
bioRxiv - Neuroscience 2023Quote: ... apolipoprotein J (ApoJ) (MCLU00, R&D Systems, Minneapolis, MN), Aβ40 (KMB3481 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and for granzyme B using human Granzyme B DuoSet ELISA (R&D Systems). All ELISAs were performed as per manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2023Quote: Recombinant human TGFβ1 (240-B R&D Systems) was stocked as 20 μg/ml in DMSO and AZ3146 (SML-1427 Sigma Aldrich ...
-
bioRxiv - Cell Biology 2020Quote: ... B-27 Serum-Free Supplement (50x) (Cat. No. 17504044, Life Technology) + 50 ng/ml FGF7 (Cat. No. 251-KG, R&D System) for 2 days ...
-
bioRxiv - Pathology 2022Quote: ... was seeded with 10 000 myoblasts in serum-free medium while the wells were filled with either proliferating medium or serum-free medium complemented with 10 ng.mL-1 FGF-b (R&D Systems 3139-FB), IGF-I (R&D Systems 791-MG ...
-
bioRxiv - Cancer Biology 2020Quote: ... Prostate-specific serum-free culture media contained 500 ng/mL human recombinant R-spondin (R&D Systems, Cat: 10820-904), 10uM SB202190 (Sigma ...
-
bioRxiv - Cancer Biology 2019Quote: ... goat anti-human Cathepsin B antibody (R&D systems AF953), goat anti human cathepsin-D antibody (Santa Cruz sc-6486) ...
-
bioRxiv - Cell Biology 2023Quote: ... recombinant human BMP4 (10 ng/ml; “B”; R&D Systems), and 100 nM retinoic acid (“Ra” ...
-
bioRxiv - Immunology 2022Quote: ... and then treated with 10 ng/mL of recombinant human TGF-b (R&D Systems; 240-B-002) or 10 ng/mL of recombinant human IL-1β (R&D Systems ...
-
bioRxiv - Molecular Biology 2023Quote: ... cells were maintained in serum-starved media with or without 10ng/ml of recombinant human TGF-β1 (R&D Systems, cat 240-B/CF) for 48 hours and harvested ...
-
bioRxiv - Immunology 2020Quote: ... or 100 U/mL human recombinant Ifn-b (R&D systems). Cells were harvested 18 hrs post-transfection ...
-
bioRxiv - Immunology 2020Quote: ... or 100 U/mL human recombinant Ifn-b (R&D systems) at the cell counts and conditions previously described for the cellular luciferase assays ...
-
bioRxiv - Cancer Biology 2021Quote: ... culture media were changed to serum free media or serum free media with 2 ug/ml IGF2 antibody (AF-292, R&D Systems) for another 72 hours ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Carrier free human FGF21 was purchased (R&D Systems). The insulin receptor antagonist peptide ...
-
bioRxiv - Cancer Biology 2023Quote: ... and carrier-free human CXCL12 protein (R&D systems) at 1:1 molar ratio and the mixture was incubated at room temperature for 2 hours ...
-
bioRxiv - Physiology 2023Quote: ... ciCMVEC were placed in serum-free media 1h before treatment with 10 ng/ml of Recombinant Human TNF-α Protein (210-TA-005; R&D systems) or vehicle (PBS ...
-
Tuning trophoblast invasion in a gelatin hydrogel via soluble cues from the maternal-fetal interfacebioRxiv - Bioengineering 2020Quote: ... Recombinant human transforming growth factor β1 (TGFβ1; R&D Systems, 240-B) and recombinant human epidermal growth factor (EGF ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was purchased from R&D systems.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was from R&D Systems (UK) and used at a final concentration of 0.5 ng/ml ...
-
bioRxiv - Cell Biology 2022Quote: ... 10 ng/mL human recombinant activin B (R&D Systems, Minneapolis, MN), 0.1 nmol/L exendin-4 (Sigma) ...
-
bioRxiv - Bioengineering 2020Quote: ... Microvascular fragment-containing gels were cultured in serum-free media supplemented with 10 ng/mL recombinant human vascular endothelial growth factor (rhVEGF; R&D Systems, Minneapolis, MN) (55) ...
-
bioRxiv - Neuroscience 2020Quote: ... Licor Biosciences) targeting apolipoprotein A1 (0.4 μg/mL; RRID: AB_2242717, cat. no. AF3664, R&D Systems, Minneapolis, MN) as an indicator of lipoproteins ...
-
bioRxiv - Genomics 2020Quote: ... the EBs were dissociated with trypsin-EDTA and reaggregated for 40 hr in serum-free differentiation media with the addition of 8ng/ml human activin A (R&D Systems Cat#. 338-AC), 0.5 ng/ml human BMP4 (R & D Systems Cat# 314-BP) ...
-
bioRxiv - Molecular Biology 2023Quote: ... according to the manufacturer’s protocol and reaggregated for 40h in serum-free differentiation media with the addition of 8 ng/ml human Activin A (R&D Systems Cat#. 338-AC), 0.5 ng/ml human BMP4 (R&D Systems Cat# 314-BP) ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Cancer Biology 2021Quote: ... and b) Goat anti-human CD4 (1:400, R&D Systems AF-379-NA) and Rabbit anti-human CD8 (1:400 ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL human basic fibroblast growth factor (b-FGF) (R&D Systems, Inc.), and 10 μM Y27632 (FUJIFILM Wako Pure Chemical Corporation ...
-
bioRxiv - Developmental Biology 2019Quote: ... NIBR0213 (Novartis) and recombinant carrier-free human VEGF-A165 (R&D systems).
-
bioRxiv - Molecular Biology 2021Quote: ... and human serum osteopontin was measured using the Human Osteopontin DuoSet ELISA kit (R&D Systems Inc.). Phosphate homeostasis hormones were measured in mouse and human serum using the FGF-23 ELISA Kit (Kainos Laboratories Inc. ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100 U/mL Penicillin/Streptomycin supplemented with 0.1% recombinant human Fetal Growth Factor b (Alamone F-170) and 0.1% recombinant human Epidermal Growth Factor (R&D systems 236-EG). On Day 12 ...
-
bioRxiv - Cell Biology 2023Quote: Primary human lung fibroblasts (passages 3-9) were exposed to 5ng/ml recombinant human TGF-β1 (R&D Systems, 240-B-002), 180μM H2O2 (Sigma ...
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 5 ng/mL recombinant human TGFβ1 (R&D Systems, 240-B) prepared according to the manufacture’s specifications ...
-
bioRxiv - Cell Biology 2021Quote: ... Recombinant human carrier-free FLRT2 protein (2877-FL) was from R&D Systems. Streptavidin-conjugated HRP was from GE Healthcare.
-
bioRxiv - Cancer Biology 2022Quote: ... Serum-starved cells were stimulated with human recombinant TGFβ1 (R&D Systems) for 16h.
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Immunology 2020Quote: ... CA) with 1% human serum and 1,200 IU/ml of recombinant human interleukin-2 (R&D Systems, Inc., Minneapolis, MN). As a positive control ...
-
bioRxiv - Physiology 2019Quote: ... fully differentiated mouse or human brown adipocytes were incubated with 100ng/ml activin B (R&D Systems) in DMEM/F12 supplemented with 10% FBS and 100µg/ml penicillin-streptomycin for 24h before lysis and for RNA extraction of RNA (as indicated below) ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant TGF-β1 (#240-B-002) and human growth hormone Genotropin (Pfizer) procured from R&D Systems.
-
bioRxiv - Molecular Biology 2022Quote: ... Human TGF-β1 (240-B) and IL-1β (201-LB-005) were purchased from R&D systems.
-
bioRxiv - Cancer Biology 2023Quote: ... Inhibitors used in the study are Recombinant Human TGF-β1 protein (R&D Systems, 240-B-002), SAHA (Sigma ...
-
bioRxiv - Cancer Biology 2024Quote: ... The lower compartment contained 500 μl of either cancer cell line derived conditioned medium or control media (serum free medium; 2% serum control; CCL19 (20 ng/mL, R&D Systems). The PBMCs were allowed to migrate from the upper chamber to the lower one for 3 hours ...
-
bioRxiv - Cancer Biology 2023Quote: ... Serum-deprived media ±recombinant human CCL8 or CCL15 (R&D Systems, Minnneapolis, MN) and ±5 μg/ml neutralizing antibodies for CCR1 ...
-
bioRxiv - Systems Biology 2019Quote: ... Sera were subjected to depletion of abundant serum proteins using Proteome Purify 12 Human Serum Protein Immunodepletion Resin (R&D Systems). Denaturing was followed by alkylation with N-ethylmaleimide and acetone precipitation ...
-
bioRxiv - Developmental Biology 2023Quote: ... Recombinant human Noggin protein-carrier free (#6057-NG/CF) was obtained from R&D systems.
-
bioRxiv - Immunology 2022Quote: ... either alone or in combination with 1 μg/ml mouse IgG2 B anti-human TIGIT (R&D systems) or 1 μg/ml goat IgG anti-human TIM-3 (R&D systems ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
bioRxiv - Cell Biology 2023Quote: ... the cells were stimulated with 2 ng/mL recombinant human TGF-β1 (R&D Systems, cat. # 240-B) diluted in starvation medium for varying durations of 30 ...
-
bioRxiv - Immunology 2022Quote: ... Human CSF-1 and IL-34 human serum levels were quantified using ELISA kits (both R&D systems, Mountain View, CA, USA), according to manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2021Quote: ... bottom chambers were filled with 500 μL of serum-free DMEM with chemoattractants (R&D Systems). Cells were cultured overnight at 37°C and 5% CO2 ...